A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and <i>Mycoplasma hyopneumoniae</i> combined vaccine.

Porcine Health Manag · 2017 · PMC5679184 · PMID 29152324

Europe PMC DOI

hedged sentence

0.0004

closest p · 0.0× alpha

0.0004

boldest claim

The sentences

highly significantp = 0.0004actually significant

Over the finishing period (10–22 weeks of age), there was a highly significant difference between both vaccinated groups and the NC group ( p = 0.0004), but not between the PCVM and FLEX groups (see Table 4 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.